Ravuconazole is a member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer). It exhibits antifungal activity by inhibition of 14alpha demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal cell wall and fungal cell death. Its therapeutic use is listed as antifungals and dermatologicals. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include BMS-207147, (Benzonitrile, 4-(2-((1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2 and 4-triazol-1-yl)propyl)-4-thiazolyl)-). Its PubChem CID is 467825.
Ravuconazole
| CAS No | 182760-06-1 |
|---|---|
| Molecular Formula | C22H17F2N5OS |
| Molecular Weight | 437.5 g/mol |
| Synonyms | 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ravuconazole is a member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer).
The listed CAS number is 182760-06-1.
The listed molecular formula is C22H17F2N5OS.
The listed molecular weight is 437.5 g/mol.
4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile.
The source lists BMS-207147, (Benzonitrile, 4-(2-((1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2 and 4-triazol-1-yl)propyl)-4-thiazolyl)-).